StudyFinder

MT2022-49: Early identification of cognitive side-effects of immunotherapy

Recruiting

This study is testing different ways to look for neurologic side effects in patients who get CAR-T therapy for their cancer.

I'm interested

Male or Female
18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• planning to have inpatient CAR-T therapy for primary cancer
• fluent in English (written or spoken)
Exclusion Criteria:

• presence of speech or hearing problem
• diagnosis of cognitive impairment

Cancer

Clinics and Surgery Center (CSC), CAR-T, Chimeric Antigen Receptor T-Cell Therapy

Veronika Bachanova - bach0173@umn.edu
Veronika Bachanova, MD
STUDY00019811
See this study on ClinicalTrials.gov

Back